Literatur
-
1 Laux G. Depressive Störungen.. In: Möller H J, Laux G, Kapfhammer H P, Hrsg Psychiatrie und Psychotherapie.. 3. Aufl. Heidelberg: Springer; 2008: 428
-
2
Uher R, Farmer A, Henigsberg N et al.
Adverse reactions to antidepressants.
Br J Psychiatry.
2009;
195
202-210
-
3
Rief W, Nestoriuc Y, Lilienfeld-Toal A von et al.
Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.
Drug Saf.
2009;
32
1041-1056
-
4 Benkert O, Hippius H. Kompendium der psychiatrischen Pharmakotherapie.. 7. Aufl. Heidelberg: Springer; 2008: 1
-
5
Sinclair L I, Christmas D M, Hood S et al.
Antidepressant-induced jitteriness / anxiety syndrome: systematic review.
Br J Psychiatry.
2009;
194
483-490
-
6
Frye M A, Helleman G, McElroy S L et al.
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Am J Psychiatry.
2009;
166
164-172
-
7
Bridge J A, Iyengar S, Salary C B et al.
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
J Am Med Assoc.
2007;
297
1683-1696
-
8
Barbui C, Esposito E, Cipriani A.
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.
Can Med Assoc J.
2009;
180
291-297
-
9
Moore T J, Glenmullen J, Furberg C D.
Prescription drugs associated with reports of violence towards others.
PLoS One.
2010;
5
e15337
-
10
Dassanayake T, Michie P, Carter G et al.
Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.
Drug Saf.
2011;
34
125-156
-
11
Brunnauer A, Laux G, David I et al.
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
J Clin Psychiatry.
2008;
69
1880-1886
-
12
Pisani F, Oteri G, Costa C et al.
Effects of psychotropic drugs on seizure threshold.
Drug Saf.
2002;
25
91-110
-
13
Steinert T, Baier H, Fröscher W et al.
Epileptische Anfälle unter der Behandlung mit Antidepressiva und Neuroleptika.
Fortschr Neurol Psychiat.
2011;
79
138-143
-
14
Madhusoodanan S, Alexeenko L, Sanders R et al.
Extrapyramidal symptoms associated with antidepressants – a review of the literature and an analysis of spontaneous reports.
Ann Clin Psychiatry.
2010;
22
148-156
-
15
Baughman K R, Bourguet C C, Ober S K.
Gender differences in the association between antidepressant use and restless legs syndrome.
Movement Disorders.
2009;
24
1054-1059
-
16
Serretti A, Mandelli L.
Antidepressants and body weight: a comprehensive review and meta-analysis.
J Clin Psychiatry.
2010;
71
1259-1272
-
17
Richards J B, Papaioannou A, Adachi J D et al.
Effect of selective serotonin reuptake inhibitors on the risk of fracture.
Arch Intern Med.
2007;
167
188-194
-
18
Woolcott J C, Richardson K J, Wiens M O et al.
Meta-analysis of the impact of 9 medication classes on falls in elderly persons.
Arch Intern Med.
2009;
169
1952-1960
-
19
Letmaier M, Painold A, Holl A K et al.
Hyponatraemia during psychopharmacological treatment: results of a drug surveillance Programme.
Int J Neuropsychopharmacol.
2011;
[Epub ahead of print]
1-10
-
20
Coupland C, Dhiman P, Morriss R et al.
Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
Br Med J.
2011;
343
d4551
-
21
Taylor D.
Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.
Acta Psychiatr Scand.
2008;
118
434-442
-
22
Cosgrove L, Shi L, Creasey D E et al.
Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers’ financial associations with industry.
PLoS ONE.
2011;
6
e18210
-
23
Caraci F, Crupi R, Drago F et al.
Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.
Curr Drug Metab.
2011;
12
570-577
-
24
Serretti A, Chiesa A.
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
J Clin Psychopharmacol.
2009;
29
259-266
-
25
Kinzl J F.
Depression und Antidepressiva: Auswirkungen auf die Sexualität.
Neuropsychiatr.
2009;
23
134-138
-
26
Milkereit A, Voderholzer U.
Absetz- und Toleranzphänomene bei Antidepressiva.
Nervenheilkunde.
2010;
5
28-288
-
27
Tuccori M, Montagnani S, Testi A et al.
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Postgrad Med.
2010;
122
49-65
-
28
Udechuku A, Nguyen T, Hill R et al.
Antidepressants in pregnancy: a systematic review.
Aust N Z J Psychiatry.
2010;
44
978-996
-
29
Occhiogrosso M, Omran S S, Altemus M.
Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
Am J Psychiatry.
2011;
DOI: 10.1176/appi.ajp.2011.11040553
-
30
Davanzo R, Copertino M, De Cunto A et al.
Antidepressant drugs and breastfeeding: a review of the literature.
Breastfeed Med.
2011;
6
89-98
Dr. med. Gabriele Hiller
Schön Klinik Roseneck
Am Roseneck 6
83209 Prien
Email: GHiller@schoen-kliniken.de
